相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sarcosine (N-Methylglycine) treatment for acute schizophrenia: A randomized, double-blind study
Hsien-Yuan Lane et al.
BIOLOGICAL PSYCHIATRY (2008)
Glycine transport inhibitors and the treatment of schizophrenia
Daniel C. Javitt
BIOLOGICAL PSYCHIATRY (2008)
Minocycline as Adjunctive Therapy for Schizophrenia: An Open-Label Study
Tsuyoshi Miyaoka et al.
CLINICAL NEUROPHARMACOLOGY (2008)
Serine racemase is predominantly localized in neurons in mouse brain
Kazushi Miya et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2008)
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline
Yuko Fujita et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Minocycline ameliorates negative symptoms and cognitive deficits in early-phase schizophrenia: A double-blind, randomized placebo-controlled study
Y. Levkovitz et al.
SCHIZOPHRENIA RESEARCH (2008)
Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site
Seong S. Shim et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2007)
The dichotomy of NMDA receptor signaling
Sofia Papadia et al.
NEUROSCIENTIST (2007)
The Cognitive and Negative Symptoms in Schizophrenia, Trial (CONSIST): The efficacy of glutamatergic agents for negative symptoms and cognitive impairments
Robert W. Buchanan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine
Lin Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Minocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophrenia
Yechiel Levkovitz et al.
BRAIN RESEARCH (2007)
Glutamate and dopamine dysregulation in schizophrenia - A synthesis and selective review
James M. Stone et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Novel therapeutics schizophrenia: Targeting glycine modulation of NMDA glutamate receptors
Stephen M. Stahl
CNS SPECTRUMS (2007)
Possible antipsychotic effects of minocycline in patients with schizophrenia
Tsuyoshi Miyaoka et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Glycine transporter I inhibitor, N-methylglycine (Sarcosine), added to clozapine for the treatment of schizophrenia
Hsien-Yuan Lane et al.
BIOLOGICAL PSYCHIATRY (2006)
Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain
Lin Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Minocycline protects PC12 cells against NMDA-induced injury via inhibiting 5-lipoxygenase activation
Ying Song et al.
BRAIN RESEARCH (2006)
D-alanine added to antipsychotics for the treatment of schizophrenia
GE Tsai et al.
BIOLOGICAL PSYCHIATRY (2006)
Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia - A randomized, double-blind, placebo-controlled study
HY Lane et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
N-methyl-D-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways:: A revolving neurochemical axis for therapeutic intervention?
JJ Haddad
PROGRESS IN NEUROBIOLOGY (2005)
N-methyl-D-aspartate receptor subtype mediated bidirectional control of p38 mitogen-activated protein kinase
EA Waxman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients
K Hashimoto et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Double-blind, placebo-controlled, crossover trial of clozapine plus glycine in refractory schizophrenia negative results
P Diaz et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data
MD Black
PSYCHOPHARMACOLOGY (2005)
A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients
DC Goff et al.
PSYCHOPHARMACOLOGY (2005)
D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia
U Heresco-Levy et al.
BIOLOGICAL PSYCHIATRY (2005)
Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis
HJ Tuominen et al.
SCHIZOPHRENIA RESEARCH (2005)
Glycine transporter I inhibitor, N-methylglycine (Sarcosine), added to antipsychotics for the treatment of schizophrenia
GC Tsai et al.
BIOLOGICAL PSYCHIATRY (2004)
High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia
U Heresco-Levy et al.
BIOLOGICAL PSYCHIATRY (2004)
Minocycline prevents glutamate-induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways
RB Pi et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Neuroprotection by tetracyclines
M Domercq et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Effects of D-cycloserine on negative symptoms in schizophrenia
EJ Duncan et al.
SCHIZOPHRENIA RESEARCH (2004)
Bringing order to the glutamate chaos in schizophrenia
B Moghaddam
NEURON (2003)
Decreased serum levels of D-serine in patients with schizophrenia - Evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia
K Hashimoto et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Maintained improvement with minocycline of a patient with advanced Huntington's disease
EM Denovan-Wright et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2002)
D-cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia
AE Evins et al.
SCHIZOPHRENIA RESEARCH (2002)
Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia
U Heresco-Levy et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Schizophrenia: the fundamental questions
NC Andreasen
BRAIN RESEARCH REVIEWS (2000)
Placebo-controlled trial of glycine added to clozapine in schizophrenia
AE Evins et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
分享论文
